​

Centessa Pharmaceuticals Ownership | Who Owns Centessa Pharmaceuticals?

OverviewForecastRevenueFinancialsChart

Centessa Pharmaceuticals Ownership Summary

Centessa Pharmaceuticals is owned by 95.99% institutional investors, 0.44% insiders, and 3.57% retail investors. Medicxi ventures management (jersey) is the largest institutional shareholder, holding 14.93% of CNTA shares. T. Rowe Price Health Sciences is the top mutual fund, with 2.22% of its assets in Centessa Pharmaceuticals shares.

CNTA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCentessa Pharmaceuticals95.99%0.44%3.57%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Medicxi ventures management (jersey)19.96M14.93%$484.11M
Avoro capital advisors10.81M8.09%$262.10M
Adage capital partners gp10.04M7.51%$243.35M
Index venture life associates vi9.96M7.45%$241.57M
General atlantic9.68M7.24%$234.78M
Fmr6.28M4.70%$152.22M
Janus henderson group4.91M4.22%$82.22M
Price t rowe associates inc /md/4.80M3.59%$116.50M
Farallon capital management4.33M3.24%$105.03M
First light asset management3.64M2.72%$88.17M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Index venture life associates vi9.96M100.00%$241.57M
Medicxi ventures management (jersey)19.96M65.03%$484.11M
Foresite capital management vi1.31M12.31%$31.86M
Allostery investments lp52.50K8.79%$689.85K
First light asset management3.64M8.31%$88.17M
General atlantic9.68M7.05%$234.78M
5am venture management680.95K6.05%$16.51M
Saturn v capital management734.54K3.91%$17.81M
Tcg crossover management3.14M3.74%$76.06M
Avoro capital advisors10.81M3.39%$262.10M

Top Buyers

HolderShares% AssetsChange
Avoro capital advisors10.81M3.39%5.81M
Janus henderson group4.91M0.04%3.61M
Fmr6.28M0.01%2.45M
Perceptive advisors3.10M2.17%1.95M
Federated hermes1.75M0.07%1.75M

Top Sellers

HolderShares% AssetsChange
Vida ventures advisors---3.93M
Holocene advisors, lp---2.26M
Point72 asset management1.07M0.04%-1.52M
Baker bros. advisors lp---1.23M
Price t rowe associates inc /md/4.80M0.01%-1.10M

New Positions

HolderShares% AssetsChangeValue
Federated hermes1.75M0.07%1.75M$42.43M
Ecor1 capital550.00K0.64%550.00K$13.34M
Logos global management lp525.00K1.14%525.00K$12.73M
Royce & associates lp247.39K0.06%247.39K$6.00M
Jain global241.97K0.03%241.97K$5.87M

Sold Out

HolderChange
Bell investment advisors-31.00
Caldwell sutter capital-43.00
Spire wealth management-70.00
Advisor group-407.00
Ronald blue trust-976.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202514010.24%128,318,6543.84%951.11%62-11.43%5047.06%
Jun 30, 2025126-10.00%123,550,297-0.00%921.08%69-9.21%34-8.11%
Mar 31, 202514118.49%124,864,8700.36%930.82%7522.95%38-
Dec 31, 202411811.32%124,412,24014.59%1071.23%60-21.05%38137.50%
Sep 30, 202410629.27%108,573,10325.51%931.50%7672.73%16-15.79%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
T. Rowe Price Health Sciences2.97M2.22%-236.58K
Fidelity Select Biotechnology2.91M2.17%-70.50K
Franklin Biotechnology Discv A(acc)USD1.18M0.88%-
Polar Capital Biotech S Inc1.00M0.75%-
Janus Henderson US SMID Cap Growth MA953.94K0.71%953.86K
Janus Henderson US SMID Cap Growth953.94K0.71%-11.25K
Janus Henderson Triton D953.94K0.71%-11.25K
American Century U.S. Small Cap Growth888.01K0.66%33.57K
American Century Small Cap Growth Inv888.01K0.66%33.57K
Fidelity VIP Mid Cap Initial702.20K0.52%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 17, 2025HUSSAIN IQBAL J General CounselSell$165.84K
Nov 17, 2025Bush Tia L Chief Technology & Quality OfcSell$1.12M
Nov 12, 2025Bush Tia L Chief Technology & Quality OfcSell$1.04M
Oct 27, 2025Accardi Mario Alberto President, Orexin ProgramSell$200.00K
Oct 15, 2025HUSSAIN IQBAL J General CounselSell$134.44K

Insider Transactions Trends

DateBuySell
2025 Q4-5
2025 Q3-14
2025 Q2212
2025 Q1-18
2024 Q4-18

CNTA Ownership FAQ

Who Owns Centessa Pharmaceuticals?

Centessa Pharmaceuticals shareholders are primarily institutional investors at 95.99%, followed by 0.44% insiders and 3.57% retail investors. The average institutional ownership in Centessa Pharmaceuticals's industry, Biotech Stocks , is 45.24%, which Centessa Pharmaceuticals exceeds.

Who owns the most shares of Centessa Pharmaceuticals?

Centessa Pharmaceuticals’s largest shareholders are Medicxi ventures management (jersey) (19.96M shares, 14.93%), Avoro capital advisors (10.81M shares, 8.09%), and Adage capital partners gp (10.04M shares, 7.51%). Together, they hold 30.53% of Centessa Pharmaceuticals’s total shares outstanding.

Does Blackrock own Centessa Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Centessa Pharmaceuticals.

Who is Centessa Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Index venture life associates vi is Centessa Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 9.96M Centessa Pharmaceuticals shares, valued at 241.57M$.

Who is the top mutual fund holder of Centessa Pharmaceuticals shares?

T. Rowe Price Health Sciences is the top mutual fund holder of Centessa Pharmaceuticals shares, with 2.22% of its total shares outstanding invested in 2.97M Centessa Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools